The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as EY Laboratories apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

EY Laboratories overview

EY Laboratories Inc (EY Labs) provides biochemical research and clinical diagnostics services. The company’s product portfolio includes affinity products, lectins and colloidal gold products. Its affinity products include affinity chromatography, avidin streptavidin biotin, carbohydrates and related, diagnostic microbiology, glycoprotein analysis kits, glycosidases, immunogold reagents and others. EY Labs offers lectin products such as colloidal gold, agarose beads, ferritin, alkaline phosphatase, dylight, biotin and blood type group, among others. The company provides diagnostic services for microbiology and other scans. Its products are used in environmental science, food science, nutrition, immunology, agriculture and plant biology, bioterrorism research and other sectors. EY Labs is headquartered in San Mateo, California, the US.

For a complete picture of STREPACHEK, Respiratory Disease Tests pricing in the US, buy the report here.


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.

Source link